全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomas

DOI: https://doi.org/10.1038/s41409-018-0417-9

Full-Text   Cite this paper   Add to My Lib

Abstract:

Relapsed/refractory Peripheral T-cell Lymphomas are characterized by a poor prognosis, especially for patients who are not candidates for allogeneic hematopoietic stem-cell transplantation. We conducted a retrospective analysis on 73 consecutive patients affected by relapsed/refractory T-Cell lymphomas who were considered eligible for allogeneic transplant. All patients were referred at our center from 2001 to 2017. With a median follow-up of 40 months (range 9–192 months), 4-year second-line failure-free survival and overall survival were 14% (CI95%:7–24) and 34% (CI95%:22–46). Extranodal disease at relapse (HR 2.25, CI95%: 1.11–4.56, p?=?0.02) and first-line failure-free survival?<?12 months (HR 3.37, CI95%: 1.67–6.88, p?<?0.01) had a negative prognostic impact on survival. Only 45 out of 73 patients (62%) received allogeneic transplant. For the 28 (38%) patients who did not proceed to transplant, disease progression was the main reason for ineligibility. Median survival from time of transplant was 31 months (range 4–185 months). A first-line failure-free survival?<?12 months had a negative prognostic impact also for allografted patients (2-year survival 45% vs 73%, p?=?0.03) identifying a very high-risk population which requires novel treatments pre and post-transplant to obtain a long-term disease control

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133